Ricochet Study

A national, multi-centre, trainee-led follow-up audit of HPB malignancy launching on 10th August 2020

[Ricochet Study @RicochetStudy]

Building on the success of the 1st RICOCHET collaborative study, we are excited to launch RICOCHET 2! Please look below for our visual abstract:

Register here: https://t.co/tBCH1HYE5O

More information about the study is available here: https://t.co/EhLGhXjXO6

[Rich Wilkin @rwilkin_1]

@RicochetStudy @AlexMMarley @Georgia_Layton @PancreaticCanUK @Dbashz @Phil_Harvey1 @siobhanmckay @rupaly_pande @DrSfpb Very pleased to be able to share this link to the full paper. https://t.co/3y5MUjMkPW
Really important to get the message about PERT prescribing out there. Thanks to @thetimes and @utv for featuring the @PancreaticCanUK #transformlivesprescribe

[Ricochet Study @RicochetStudy]

Gaining national interest... https://t.co/pYGVz2wOVH

[Prof Keith Roberts @UHB_HPB]

Really pleased to see the first output from our RICOCHET national pancreatic cancer audit. Variation and underuse of PERT despite NICE guidance. Many patients are wasting away and suffering needlessly. Thank you to all Collaborators, trainees and steering group

[Ricochet Study @RicochetStudy]

Despite clinical consensus that PERT is crucial for people with pancreatic cancer, & recommendations by NICE, only half are being prescribed PERT. 

We are joining @PancreaticCanUK’s campaign for PERT to be made UK-wide priority in pancreatic cancer care! #TransformLivesPrescribe

[Ricochet Study @RicochetStudy]

Read the pre-print here: https://t.co/jaVfnQxZrX

(*Authorship to be corrected to fully collaborative for publication*)

[Ricochet Study @RicochetStudy]

Thanks to the brilliant work of all our collaborators, we will soon be publishing ‘Pancreatic enzyme replacement therapy in patients with pancreatic cancer’ - #PERT is a key component of #pancreaticcancer care but we are not doing enough to provide it to our patients yet!

[Ricochet Study @RicochetStudy]

Right now, half of pancreatic cancer patients are not getting the prescription they need to be able to digest their food. Together we can change this. 

#RememberPERT

[Ricochet Study @RicochetStudy]

Thanks to the brilliant work of all our collaborators, we will soon be publishing ‘Pancreatic enzyme replacement therapy in patients with pancreatic cancer’ - #PERT is a key component of #pancreaticcancer care but we are not doing enough to provide it to our patients yet!

[Siobhan Mckay @siobhanmckay]

Really important Study, needs international collaboration to feedback rapidly the impact on patients of potential delays in cancer surgery due to COVID-19 @roux_group @RicochetStudy @AUGISt_UK @Augishealth @IHPBA @ImprovePanc @OGAAudit @GBIHPBAnews @OfficialPCA @PancreaticCanUK

[Ricochet Study @RicochetStudy]

Join our committee member @siobhanmckay at the PSGBI webinar on Thursday 21st Jan https://t.co/8637ZDQWwy to hear our most recent results!

[Siobhan Mckay @siobhanmckay]

Join us for the results of the @RicochetStudy at PSGBI webinar 21st Jan https://t.co/MBf0zovrsJ. How long does it take from presentation to treatment plan for a patient with pancreatic cancer? @UHB_HPB @ThePancSocGBI @markataylor16 @deLiguoriCarino @DerekAOReilly @gourabsen70

[Ricochet Study @RicochetStudy]

Please remember tomorrow is your last day to review the recent manuscript that we circulated to collaborators.

Please check authorship and leave any comments/suggestions by 5pm!

[Ricochet Study @RicochetStudy]

Please note that only teams/sites who submitted data on pancreatic enzyme replacement therapy, which was therefore used within this analysis, will be credited within this manuscript.

*Future manuscripts will be ready soon so please keep an eye on your inboxes and this feed!*

[Ricochet Study @RicochetStudy]

*All collaborators should have received an email today containing our most recent manuscript.*

There are a number of bounce backs due to emails no-longer in use. If you have not received our email, please contact us at [email protected] urgently!

[Ricochet Study @RicochetStudy]

You have one week, until 5pm on Sunday 15th November 2020, to add any comments to the manuscript about the data or authorship. Changes will not be possible after this time.

[Ricochet Study @RicochetStudy]

If your centre hasn’t yet contributed to RICOCHET 2 – the 2 year follow-up study of the RICOCHET cohort, please register via the link below! With concise data collection points for the original RICOCHET patients, this is a time-efficient study!

https://t.co/tBCH1HYE5O

[Ricochet Study @RicochetStudy]

Please submit any suggestions and triple check all authorship details for you and your team - you have until 5pm on Sunday 15th November! No changes will be accepted after this time.

Thanks for all your on-going support!

#RicochetStudy

[Ricochet Study @RicochetStudy]

Watch your inboxes... Our latest manuscript looking at pancreatic enzyme replacement therapy (PERT) will be emailed to all collaborators today!!

Please review the paper; we welcome any feedback, which can be added onto the google document via the 'add comment' function.

[Ricochet Study @RicochetStudy]

Registrations are coming in at full speed! Don’t miss out on the opportunity in HPB collaborative research.
Sign up via this link: https://t.co/BLhLhGZFgN

[Ricochet Study @RicochetStudy]

Couldn't agree more! Please sign up to this exciting collaborative follow up study via this registration link:
https://t.co/tBCH1HYE5O

[The Roux Group @roux_group]

#HPB trainees- take note of the follow up study to @RicochetStudy Phase 1 and get your teams signed up
@Augishealth @GBIHPBAnews @markataylor16 @liveRPancSurg @UHB_HPB @gourabsen70 @DerekAOReilly @amsmithleeds @BhardwajNeil @HpbLeicester @hpbnorth